Plasma serotonin and platelet aggregation during ischemia-reperfusion in dogs: Effect of dipyridamole and coenzyme Q10

Pathophysiology of Haemostasis and Thrombosis

Volumn 26, Issue 1, 1996, Pages 38-44

  Choudhury, Niaz Ahmed ^a   Malyszko, Jolanta ^a   Ahmed, Motahar Hossain ^a   Pietraszek, Michal Henryk ^a   Nakamura, Satoshi ^a   Nakai, Katsuhiko ^a   Rashid, Mohammad Abdur ^a   Takada, Akikazu ^a   Baba, Shozo ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Coenzyme Q10; Dipyridamole; Ischemia; Platelet aggregation; Reperfusion; Serotonin

Indexed keywords

DIPYRIDAMOLE; SEROTONIN; UBIDECARENONE;

ARTICLE; CONTROLLED STUDY; DOG; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; THROMBOCYTE AGGREGATION;

ANIMALS; DIPYRIDAMOLE; DOGS; DRUG EVALUATION, PRECLINICAL; INTESTINES; MALE; PLATELET AGGREGATION INHIBITORS; REPERFUSION INJURY; SEROTONIN; UBIQUINONE;

EID: 0030061075     PISSN: 14248832     EISSN: 14248840     Source Type: Journal    
DOI: 10.1159/000217186     Document Type: Article

References (19)

1. Granger DN, Rutili G, McCord JM: Superoxide radicals in feline intestinal ischemia. Gastroenterology 1981;81:22-29.
2. Granger DN, Sennett M, McElear-mey P, Taylor AE: Effect of local arterial hypotension on cat intestinal capillary permeability. Gastroenterology 1980;79:474-480.
3. Granger DN, Taylor AE: Permeability of intestinal capillaries to cndo-geneous macromolecules. Am J Physiol 1980;238:H457-H466.
4. Schoenberg MH, Younes M, Muhl E, Haglund U, Sellin D, Scildberg FW: Free radical involvement in ischemic damage of the small intestine; in Greenwald RA, Cohen G (eds): Oxyradicals and Their Scavenger System. New York, Elsevier Biomedical, 1983, vol 2: Cellular and Medical Responses, pp 154-158.
5. Otamiri T, Lindahl M, Tagesson C: Phospholipase A2 inhibition prevents mucosal damage associated with small intestine ischemia. Gut 1988;29:489-494.
6. De Clerck F, van Nueten JM, Rene-man RS: Platelet-vessel wall interactions: Implications of 5-hydroxy-tryptamine. A review. Agents Actions 1984;15:612-626.
7. Bom GVR: Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962,194: 927-929.
8. Anderson GM, Young JG, Cohen DJ. Schlicht KR, Patel N: Liquid-chromatographic determination of serotonin and tryptophan in whole blood and plasma. Clin Chem 1981; 27:775-776.
9. Pietraszck MH, Choudhury NA, Baba S, Sakaguchi S, Hachiya T, Urano T, Takada Y, Takada A: Serotonin as a factor involved in pathophysiology of thromboangiitis obliterans. Int Angiol 1993; 12:9-12.
10. Van Zwieten PA: Pathophysiological relevance of serotonin. J Car-diovasc Pharmacol 1987;10(suppl 3):S19-S25.
11. Dawicki DD, Agarwal KC, Parks RE: Potentiation of the antiplatelct action of adenosine in whole blood by dipyridamole or dilazep and the c-AMP phosphodiesterase inhibitor, RA 233. Thromb Res 1986;43:161-166.
12. Parks DA, Shah AK, Granger DN: Oxygen radicals: Effects on intestinal vascular permeability. Am J Physiol 1984;247:G167-G170.
13. Caplan MS, Hedlund E, Hill N, Mac Kendrick W: The role of endogenous nitric oxide and platelet-activating factor in hypoxia-induced intestinal injury in rats. Gastroenterology 1994:106:346-352.
14. Moncada S, Vane JR: Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2 and prostacyclin. Pharmacol Rev 1979;30:293-331.
15. Packham MA, Nishizawa EE, Mustard JF: Response of platelets tissue injury. Biochcm Pharmacol 1968; suppl 7:171-184.
16. Lugnicr CP, Schoeffer P, Le Bee A, Strouthou E, Stoclet JC, Strasbourg FR: Selective inhibition of cyclic nucleotide phosphodiesterase of human, bovine and rat aorta. Biochcm Pharmacol 1986;35:1743-1750.
17. Crutcheley DJ. Ryan US, Ryan JW: Effects of aspirin and dipyridamole on the degradation of adenosine diphosphate by cultured cells derived from bovine pulmonary artery. J Clin Invest 1980;66:29-34.
18. Tremoli E, Colli S: Dipyridamole inhibits superoxide anion generation by human neutrophils. Thromb Haemost 1988;59:342.
19. Best LC, McGuire MB, Jone PBB: Mode of action of dipyridamole on human platelets. Thromb Res 1979; 16:367-379.